Literature DB >> 8576446

Fate of GABAergic septohippocampal neurons after fimbria-fornix transection as revealed by in situ hybridization for glutamate decarboxylase mRNA and parvalbumin immunocytochemistry.

P Kermer1, T Naumann, R Bender, M Frotscher.   

Abstract

Many septohippocampal neurons are GABAergic and are affected by transection of the fimbria-fornix, like the septohippocampal cholinergic cells. Here we have studied the changes that occur in GABAergic septohippocampal neurons following fimbria-fornix transection. For labeling of septohippocampal projection neurons, adult Sprague-Dawley rats received injections of the fluorescent tracer Fluoro-Gold into the hippocampus 1 week prior to bilateral transection of the fimbria-fornix. After axotomy, rats were allowed to survive for varying periods ranging from 3 weeks to 18 months. Following fixation of the animals, sections through the septal region were either stained by in situ hybridization for glutamate decarboxylase (GAD) mRNA or immunostained for parvalbumin (PARV), which is known to be present in GABAergic septohippocampal neurons. In situ hybridization for GAD mRNA revealed no statistically significant changes in cell number 3 weeks and 6 months postlesion. In contrast, PARV-immunoreactive neurons were reduced to 35% of control 3 weeks postlesion. This value increased to 66% after 6 months of survival. As seen in the electron microscope, axotomized PARV-positive neurons exhibited characteristics of vital cells. Most neurons contained lysosomes associated with Fluoro-Gold, resulting from retrograde labeling prior to fimbria-fornix transection. We conclude that mainly PARV-containing GABAergic neurons in the medial septal nucleus (MS) project to the hippocampus and are thus heavily affected by the lesion but are able to survive and restore the synthesis of PARV. The lack of significant changes in the number of GAD mRNA-expressing cells is explained by the presence of numerous GABAergic MS neurons not projecting to the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576446     DOI: 10.1002/cne.903620307

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  Firing properties of anatomically identified neurons in the medial septum of anesthetized and unanesthetized restrained rats.

Authors:  Axelle Pascale Simon; Frédérique Poindessous-Jazat; Patrick Dutar; Jacques Epelbaum; Marie-Hélène Bassant
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

2.  The role of cholinergic and GABAergic medial septal/diagonal band cell populations in the emergence of diencephalic amnesia.

Authors:  J J Roland; L M Savage
Journal:  Neuroscience       Date:  2009-03-03       Impact factor: 3.590

3.  Axotomy-induced neurotrophic withdrawal causes the loss of phenotypic differentiation and downregulation of NGF signalling, but not death of septal cholinergic neurons.

Authors:  Oscar M Lazo; Jocelyn C Mauna; Claudia A Pissani; Nibaldo C Inestrosa; Francisca C Bronfman
Journal:  Mol Neurodegener       Date:  2010-01-19       Impact factor: 14.195

4.  Activation of STAT3 signaling in axotomized neurons and reactive astrocytes after fimbria-fornix transection.

Authors:  Klaus Oliver Schubert; Thomas Naumann; Oliver Schnell; Qixia Zhi; Andreas Steup; Hans-Dieter Hofmann; Matthias Kirsch
Journal:  Exp Brain Res       Date:  2005-07-01       Impact factor: 1.972

5.  The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1.

Authors:  Lorenza Magno; Oliver Kretz; Bettina Bert; Sara Ersözlü; Johannes Vogt; Heidrun Fink; Shioko Kimura; Angelika Vogt; Hannah Monyer; Robert Nitsch; Thomas Naumann
Journal:  Eur J Neurosci       Date:  2011-11-18       Impact factor: 3.386

6.  Injection of Fluoro-Gold into the tibial nerve leads to prolonged but reversible functional deficits in rats.

Authors:  Daguo Mi; Ying Yuan; Yanping Zhang; Jiahui Niu; Yaxian Wang; Junying Yan; Yumin Yang; Wen Hu
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.